Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Merck

Can The No. 1 Pharma Stock, Merck, Continue Its Blazing Run In 2023?

Merck is navigating a looming patent expiration for its blockbuster Keytruda. Now, Merck stock is trading at its highest point in decades.

Investors Business Daily

Chinese take risks on black-market Covid drugs

BEIJING: Desperate families searching for critical Covid-19 medication in China, faced with bare pharmacy shelves and an explosion of cases, are being driven into murky online marketplaces rife with price gouging and fraud.

Bangkok Post

Lisa Jarvis: Cancer vaccine hunt makes progress, finally

The long-awaited cancer vaccine revolution is getting a little closer to reality. New data from Moderna Inc. and Merck & Co. suggest that after decades of failures, researchers are finally figuring out the right way to design a vaccine that can teach immune cells how to recognize and combat tumors.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

3 High-Flying Pharma Stocks to Buy Right Now

The healthcare industry is poised to grow significantly in the coming years. Moreover, as healthcare stocks tend to perform relatively well despite macro uncertainties due to inelastic demand for their products and services, high-flying pharma stocks Novo Nordisk (NVO), AbbVie (ABBV), and Merck & Co (MRK) might be ideal investments…

StockNews.com

Arcus, Gilead Disappoint As Lung-Cancer Regimen Lags Rival Roche

Gilead and Arcus toppled Tuesday after their lung-cancer regimen trailed a rival concoction from Roche. RCUS stock skidded more than 20%.

Investors Business Daily

Red-Hot Fund Managers Expect Rocky Start To 2023

Want to know how to invest in 2023? Red-hot fund manager Dale Harvey says individual investors should fasten their seat belts.

Investors Business Daily

Market Rally Pressured On Fed Rate Outlook; Moderna, Boeing, Tesla In Focus: Weekly Review

The market rally came under pressure on a higher Fed rate outlook. Moderna spiked on a cancer vaccine while Tesla continued to dive.

Investors Business Daily

Read news from The Economist, FT, and more,
with one subscription

Ebola vaccines produced lasting antibodies during trial: Studies

Studies in West Africa said the vaccines developed by Johnson & Johnson and Merck & Co appear to be safe in children.

Al Jazeera

J&J and Merck Ebola vaccines produce lasting antibodies in children and adults -studies

Ebola vaccines developed by Johnson Johnson and Merck Co produced virus-fighting antibodies and appear to be safe in children and adults, according to data from two studies published on Wednesday.

Reuters

Cancer vaccine halves risk of relapse or death using Covid jab technology

Jab led to reduction in risk of cancer coming back or death in patients with stage three and four melanoma

The Independent UK

Skin cancer vaccine trial shows promising results

Moderna and Merck team up in new study.

Fortune

Dow Jones Rallies; Elon Musk Loses This Title As Tesla Tumbles; Bitcoin Up Amid Sam Bankman-Fried Arrest

The Dow Jones moved higher. Tesla CEO Elon Musk lost a famous title. Bitcoin rose after the Sam Bankman-Fried arrest. Moderna stock jumped.

Investors Business Daily

Researchers from Moderna and Merck just made a breakthrough with a skin cancer vaccine

Thank you, science.

Mic

Stock Market Rally, New Breakouts Fade At Midday As CPI Enthusiasm Wanes

The stock market's reaction to the inflation data was swift and decisive.

Investors Business Daily

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

Merck, Moderna detail potential skin cancer vaccine progress

Shares of Merck and Moderna jumped early Tuesday after the drugmakers said a potential skin cancer vaccine they are developing using the same technology behind COVID-19 preventive shots did well in a mid-stage study

Investors Business Daily

Moderna Stock Breaks Out As Cancer Vaccine Shows Promise In Keytruda Tie-Up

Moderna unveiled promising results for its personalized cancer vaccine on Tuesday. The results sent Moderna shares soaring.

Reuters

Indonesia to produce Merck's HPV vaccines to combat cervical cancer

Indonesia will produce drugmaker Merck Co's vaccines for human papillomavirus (HPV), the chief of its state-owned pharmaceutical company Bio Farma said on Tuesday, in a bid to combat HPV-linked cervical cancer in the country.

Investors Business Daily

Mirati Wins FDA Approval For Amgen-Rivaling Cancer Drug As Wild Stock Swing Continues

The Food and Drug Administration approved Mirati's rival to Amgen's lung cancer drug, sending MRTX stock higher on Tuesday.

Get all your
news in one place.

100’s of premium titles.
One news app.

Investors Business Daily

Hot Fund To SEC: We're Boosting Bets On Best Stock Picks

Wondering how to invest in stocks and mutual funds amid a grim market? Red-hot Invesco Comstock Select Fund is doubling down on its strategy.

StockNews.com

3 Stocks Insiders Can’t Stop Buying This Month

After signs of cooling inflation, investors are hopeful that the Fed will slow its rate hikes over the coming months. With surging optimism, fundamentally strong stocks Merck (MRK), Coca-Cola (KO), and Verizon (VZ), which have seen increased insider buying, might be ideal investments now. Continue reading.

Investors Business Daily

Mirati Therapeutics Surges As Big Pharma Reportedly Preps For A Buyout Battle

Big Pharma suitors could be looking to buy Mirati Therapeutics, according to reports that sent MRTX stock close to a breakout Wednesday.

Investors Business Daily

See Why Gilead's Cancer Business Is Driving The Stock To A Fever Pitch

Gilead Sciences' first-in-class cancer drug and GILD stock are finally hitting their stride. The oncology business is growing bullishly.

Investors Business Daily

Imago BioSciences Catapults To Record High On Merck's $1.35 Billion Buyout

Biotech stock Imago BioSciences broke out and hit a record high Monday after Merck pledged to buy it for $1.35 billion.

Investors Business Daily

Dow Jones Surges 900 Points On Cool Inflation Data; Treasury Yields Dive

The Dow Jones Industrial Average surged 900 points Thursday on cool inflation data, with the consumer price index (CPI) coming in lower than expected.

WEKU

Uganda ends school year early as it tries to contain growing Ebola outbreak

Since the outbreak began in September, eight children have died — and there is no approved vaccine. But doctors are hopeful that public health measures may be enough to stop the spread.

1 … 11 12 13 14

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.